연구물
20건 검색
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis
Song, Ga-YoungJung, Sung-HoonLee, Je-JungKim, Jin SeokMin, Chang-Ki신호진외 15명
- 연구출판물 · 학술지 논문JCR Q4Scopus Q4Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)
Jung, Sung-HoonLee, Je-JungKim, Jin SeokMin, Chang-KiKim, Kihyun신호진외 14명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Efficacy and safety of the BEBM (bendamustine, etoposide, busulfan, and melphalan) conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma
- 연구출판물 · 학술지 논문Scopus Q3A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
Kim, Min KyoungKim, KihyunMin, Chang-KiKwak, Jae-YongBae, Sang-Byung신호진외 38명
- 연구출판물 · 학술지 논문JCR Q2Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multip
Eom, Hyeon-SeokKim, Yeo-Kyeoung정주섭Kim, KihyunKim, Hyo Jung외 9명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q1Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
김경하이재훈Lee, Mark김훈구도영록신호진외 11명
- 연구출판물 · 학술지 논문Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma
Kim, Seok JinKim, KihyunKim, Byung SooLee, Hyo-JinKim, Hawk신호진외 14명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study
Jung, JongheonChoi, Yoon SeokLee, Jae HoonLee, Won SikKim, Sung-hyun신호진외 11명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma
Lee, Gyeong-WonPark, Sung WooGo, Se-IlKim, Hoon-GuKim, Min Kyoung신호진외 40명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea
Kim, Da JungJeong, SeriKong, Seom Gim이상진Lim, Sung-Nam외 8명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
Suzuki, KenshiWechalekar, Ashutosh D. D.Kim, KihyunShimazaki, ChihiroKim, Jin Seok신호진외 16명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed
Kim, Hye JinYoon, Sung-SooLee, Dong SoonSohn, Sang KyunEom, Hyeon Seok정주섭외 11명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q1Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells
- 연구출판물 · 학술지 논문JCR Q2Scopus Q3Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
Lee, Ho SupKim, Yang SooKim, KihyunKim, Jin SeokKim, Hyo Jung정주섭외 10명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy



로그인
홈
Researcher Page
ORCID
ISNI